Back

Impact of recurrent heart failure hospitalizations on cardiovascular mortality in subpopulations with atrial fibrillation and Type 2 diabetes mellitus in a UK database

2 September 2019 (11:18 - 11:36)
Organised by:
Congress Presentation Part of: Heart failure and diabetes: what is on the horizon Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Rachel Studer

Novartis Pharma AG, Basel (Switzerland)

4 More presentations in this session

Presentation thumbnail
State of the Art -Diabetes and heart failure: complex interactions
Professor S. Anker (Berlin, DE)
Slides Video
Presentation thumbnail
Impact of heart failure on prognosis compared to other complications in patients with diabetes mellitus type 2
Mrs B. Zareini (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Impact of type 2 diabetes on incidence and phenotype of heart failure in patients with atrial fibrillation
Doctor M. Polovina (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Tackling the growing burden of diabetes and cardiovascular disease: introducing a Roadmap on cardiovascular disease and diabetes.
Doctor L. Sperling (Atlanta, US)
Slides Video

Access the full session

Session thumbnail
Heart failure and diabetes: what is on the horizon

The Event

Event poster

ESC Congress 2019

2 September 2019 11:18 CET